1. Inflammation and Cancer: Role of Tight Junctions
   Kristina Pravoverov et al, 2023, Tight Junctions in Inflammation and Cancer CrossRef
2. Oncolytic Viruses in Combination Therapeutic Approaches with Epigenetic Modulators: Past, Present, and Future Perspectives
   Annalisa Chianese et al, 2021, Cancers CrossRef
3. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells
   Lotte M.E. Berghauser Pont et al, 2015, PLOS ONE CrossRef
4. Association of oncolytic adenoviruses with chemotherapies: An overview and future directions
   Christian Bressy et al, 2014, Biochemical Pharmacology CrossRef
5. Cisplatin Synergistically Enhances Antitumor Potency of Conditionally Replicating Adenovirus via p53 Dependent or Independent Pathways in Human Lung Carcinoma
   Sakhawat Ali et al, 2019, International Journal of Molecular Sciences CrossRef
6. Presence of the Coxsackievirus and Adenovirus Receptor (CAR) in human neoplasms: a multitumour array analysis
   M Reeh et al, 2013, British Journal of Cancer CrossRef
7. Histone deacetylase inhibitor trichostatin A enhances the antitumor effect of the oncolytic adenovirus H101 on esophageal squamous cell carcinoma in vitro and in vivo
   Junfen Ma et al, 2017, Oncology Letters CrossRef
8. Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
   Joseph Hoare et al, 2018, Porto Biomedical Journal CrossRef
9. Epigenetic therapy in gastrointestinal cancer: the right combination
   Eihab Abdelfatah et al, 2016, Therapeutic Advances in Gastroenterology CrossRef
10. Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells
    Nian-Hua Zhang et al, 2016, Oncology Reports CrossRef
11. Targeting the Microenvironment in Esophageal Cancer
    Lei Wang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
12. Histone deacetylase inhibitor boosts anticancer potential of fusogenic oncolytic vaccinia virus by enhancing cell–cell fusion
    Motomu Nakatake et al, 2024, Cancer Science CrossRef
13. Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid
    Christian Bressy et al, 2017, Oncotarget CrossRef
14. Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers
    Angela Lopomo et al, 2018, Expert Review of Gastroenterology & Hepatology CrossRef
15. Recombinant human adenovirus type 5 promotes anti-tumor immunity via inducing pyroptosis in tumor endothelial cells
    Zhi-ming Wang et al, 2024, Acta Pharmacologica Sinica CrossRef
16. Coxsackievirus B transmission and possible new roles for extracellular vesicles
    Jameel M. Inal et al, 2013, Biochemical Society Transactions CrossRef
17. Loss of coxsackie and adenovirus receptor expression in human colorectal cancer: A potential impact on the efficacy of adenovirus-mediated gene therapy in Chinese Han population
    Ying-Yu Ma et al, 2016, Molecular Medicine Reports CrossRef